Written on: March 25, 2025 by SprayTM
Aerogen, the Ireland-based global provider of acute-care aerosol drug delivery solutions, opened its India headquarters in the National Capital Territory of Delhi. The new office was officially inaugurated by James Lawless, Ireland’s Minister for Higher Education, Research & Innovation, during his visit to India on the occasion of Ireland’s National Day—St. Patrick’s Day.
L to Rt: Debjani Pal, VP India & South Asia, Enterprise Ireland; Ross Curran, Director, India &South Asia, Enterprise Ireland; James Lawless, Minister for Further & Higher Education, Research, Innovation & Science, Ireland; Richa Porwal Mehra, Regional Business Manager, North & West, Aerogen India; Mousumi Chatterjee, Regional Business Manager, East & South, Aerogen India; Esha Dayama, Key Account Manager, Aerogen India; Kevin Kelly, Ambassador of Ireland to India; Hannah Yuill, Senior Commercial Director, APAC, Aerogen Ltd.; and Debabrata Bhowmick, Commercial Director, Aerogen India.
The expansion underscores Aerogen’s commitment to supporting India’s growing healthcare sector by improving access to its aerosol drug delivery solutions, said the company. With over 55 million people in India suffering from chronic obstructive pulmonary disease (COPD) and a rising rate of respiratory diseases, Aerogen’s vibrating mesh nebulizer technology is poised to support Indian healthcare providers in delivering respiratory care to patients. The company’s drug delivery system is already used in Europe and the U.S.
Speaking at the opening, Lawless, stated, “This milestone strengthens the ties between India and Ireland, reinforcing our shared commitment to healthcare innovation.
“Aerogen’s decision to establish its presence in India is a testament to the country’s rapidly advancing healthcare ecosystem. We look forward to fostering a borderless enterprise where bilateral collaboration in innovation and research benefits both India and Ireland,” he continued.
The opening of the India headquarters represents a major investment in the APAC region and reinforces Aerogen’s long-term vision for India. The new office in New Delhi will serve as the operational hub for a growing team of experts, including a country director, marketing professionals, commercial sales specialists and clinical experts. Starting with 14 team members, Aerogen plans to expand to 30 employees over the next five years to support its growth and market penetration.
Hannah Yuill, Senior Commercial Director APAC at Aerogen said, “Aerogen is dedicated to ensuring that hospitals and patients in India have access to the most advanced aerosol drug delivery systems.
“With India’s large population and the increasing prevalence of respiratory diseases, our expansion is a crucial step in supporting the healthcare system in delivering superior patient care safely and effectively. This investment in India is a vital part of our strategy to expand across the APAC region and collaborate closely with healthcare professionals to improve respiratory treatment outcomes,” added Yuill.
Designed to foster innovation and collaboration, the India headquarters features state-of-the-art meeting rooms, private offices, a reception area, a library, a gym and yoga space and a recreation zone. Aerogen’s India expansion has been supported by Enterprise Ireland, the Irish government agency that helps Irish businesses scale internationally.
Ross Curran, Director, India & South Asia, Enterprise Ireland, shared, “Ireland is a global leader in medtech innovation, and Aerogen is at the forefront of this advancement. Their expansion in India highlights not only their commitment to enhancing respiratory care worldwide but also the deepening economic and business collaborations between Ireland and India.”
